Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ATCI: The Future of Laser Vision Correction? -- Ignore unavailable to you. Want to Upgrade?

To: Oblivious who wrote (23)	2/14/1998 9:49:00 AM
From: pappy	Read Replies (1) \| Respond to of 27

Im happy for those that are holding ATCI but there are some problems that the company could face pursuant to the excerpt from their latest 10-Q. In talking with Summit Technology in January, they did mention ATCI and that there is a close relationship and they hope to avoid the problems with ATCI that they have had with VISX. Here is that excerpt from the 10-Q and I hope the stock does well. I even hope Summit acquires ATCI since they are actively looking for an acquisition candidate and IMO, ATCI would fit in well with Summit's growth plans (A new machine with no real R & D involved that could compete with the VISX machine) which would allow stockholders of both BEAM (lots of cash) and ATCI (lack of cash) to benefit: ------------------------------------------------------------------------------------------------------------- Legal expenses that relate to the Company's pursuit, beginning in the latter half of 1996, of two legal actions and the defense of another, all having to do with alleged infringement, unenforceability and invalidity of certain LVC patents held in various jurisdictions by other participants in the LVC industry. At the end of the first quarter of 1997, the Company was able to reach a settlement in two of those three cases whereby the Company received a license to utilize certain patents outside the U.S. As a result of these settlement negotiations, legal expenses increased in the first and second quarters of 1997 to over $100,000 per month. In the third quarter, as the remaining suit is in a pre-discovery stage, the legal expenses were somewhat reduced. The Company is still pursuing, as the plaintiff, one remaining case in the U.S. and expects, as activity in that suit progresses, to incur at least $100,000 per month of legal expenses indefinitely into the future in connection with this action. There can be no assurance that the continued pursuit of this remaining case will result in any change in commercial terms for the Company's LADARVision System in the U.S. Further, there can be no assurances that other legal matters will not be opened that the Company cannot presently foresee. Pappy...